Shin Nippon Biomedical Laboratories, Ltd. (FRA:YB3)

FRA:YB3 Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 8, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	372	368	387	793	523	224
Market Cap Growth	-10.37%	-4.96%	-51.14%	51.44%	133.49%	20.59%
Enterprise Value	518	517	472	848	550	283
Last Close Price	8.75	8.80	8.67	16.99	10.96	4.64
PE Ratio	13.88	12.10	11.43	18.89	9.91	7.95
PS Ratio	1.86	1.84	2.39	4.56	3.98	1.93
PB Ratio	1.69	1.49	1.85	4.34	3.58	1.84
P/TBV Ratio	1.80	1.57	1.98	4.67	3.65	1.88
P/FCF Ratio	29.66	-	-	-	16.01	7.91
P/OCF Ratio	7.49	8.47	30.01	28.59	11.86	6.13
EV/Sales Ratio	2.75	2.58	2.91	4.88	4.18	2.44
EV/EBITDA Ratio	10.61	14.96	12.76	17.89	13.81	9.90
EV/EBIT Ratio	16.03	28.04	18.49	23.35	17.68	14.55
EV/FCF Ratio	41.33	-	-	-	16.82	10.00
Debt / Equity Ratio	1.00	0.86	0.77	0.71	0.46	0.80
Debt / EBITDA Ratio	6.37	6.16	4.34	2.74	1.70	3.41
Debt / FCF Ratio	17.50	-	-	-	2.07	3.45
Asset Turnover	0.39	0.38	0.40	0.52	0.47	0.40
Inventory Turnover	1.30	1.24	1.24	2.06	1.91	1.87
Quick Ratio	0.61	0.63	0.69	0.73	0.79	0.86
Current Ratio	1.10	1.13	1.31	1.14	1.21	1.24
Return on Equity (ROE)	12.29%	13.10%	18.24%	26.26%	40.30%	22.82%
Return on Assets (ROA)	2.05%	2.21%	3.90%	6.79%	6.88%	4.16%
Return on Capital (ROIC)	2.50%	2.77%	4.93%	8.86%	9.14%	5.28%
Return on Capital Employed (ROCE)	4.70%	4.70%	7.90%	14.50%	16.20%	10.10%
Earnings Yield	7.21%	8.27%	8.75%	5.29%	10.09%	12.58%
FCF Yield	3.37%	-6.41%	-10.25%	-0.73%	6.25%	12.64%
Dividend Yield	3.41%	3.51%	3.53%	2.04%	2.03%	1.66%
Payout Ratio	45.14%	42.65%	37.48%	41.01%	11.60%	5.65%
Buyback Yield / Dilution	-	-	-	0.00%	-	-
Total Shareholder Return	3.41%	3.51%	3.53%	2.04%	2.03%	1.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.